Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
7
78%
Ph phase_3
2
22%

Phase Distribution

7

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
7(77.8%)
Phase 3Large-scale testing
2(22.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(7)

Detailed Status

Completed7
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 17 (77.8%)
Phase 32 (22.2%)

Trials by Status

completed778%
active_not_recruiting222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9